Atlas Trials

A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women

Clinical trial NCT01143194 · COMPLETED

Trial details

NCT number
NCT01143194
Sponsor
dsm-firmenich Switzerland AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AttentionMemoryAlertness
Start date
2010-03-01
Primary completion
2010-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.